Literature DB >> 4380729

The treatment of psychiatric patients by simultaneous use of electroconvulsive and pharmacoconvulsive therapy.

Q R Regestein, P Roper.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4380729      PMCID: PMC1936836     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Inhalation Indoklon convulsive therapy.

Authors:  L J PADULA; W KARLINER
Journal:  J Neuropsychiatr       Date:  1963-02

2.  Inhalant and intravenous indoklon in psychiatric treatment.

Authors:  D J IMPASTATO; C BUCKMAN; P MILICI; I PINSLEY; A KRELL; A IMPASTATO; L PADULA
Journal:  Dis Nerv Syst       Date:  1960-09

3.  The limbic system and EST seizures.

Authors:  G D SAUL; M FELD
Journal:  Compr Psychiatry       Date:  1960-10       Impact factor: 3.735

4.  Further clinical studies of hexafluorodiethyl ether convulsive treatments.

Authors:  W KARLINER; L J PADULA
Journal:  J Neuropsychiatr       Date:  1962 Jan-Feb

5.  New pharmacoconvulsive agent.

Authors:  J C KRANTZ; E B TRUITT; L SPEERS; A S LING
Journal:  Science       Date:  1957-08-23       Impact factor: 47.728

6.  Anesthesia. LV. The pharmacologic response to hexafluorodiethyl ether.

Authors:  J C KRANTZ; E B TRUITT; A S LING; L SPEERS
Journal:  J Pharmacol Exp Ther       Date:  1957-11       Impact factor: 4.030

7.  Treatment of the chronic paranoid schizophrenic patient.

Authors:  D E CAMERON; S K PANDE
Journal:  Can Med Assoc J       Date:  1958-01-15       Impact factor: 8.262

  7 in total
  1 in total

1.  Drug addiction, psychotic illness and brain self-stimulation: effective treatment and explanatory hypothesis.

Authors:  P Roper
Journal:  Can Med Assoc J       Date:  1966-11-19       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.